Thermo Fisher Scientific (TMO) – Company Press Releases
-
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 24, 2024
-
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
-
Thermo Fisher Scientific to Present at TD Cowen 44th Annual Health Care Conference on March 6, 2024
-
Thermo Fisher Scientific Increases Quarterly Dividend
-
CIBC Expands CDR Line-Up With 7 New CDR Tickers on Cboe Canada
-
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 Results
-
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
-
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.
-
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
-
Thermo Fisher Scientific to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
-
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, January 31, 2024
-
Madryn Asset Management Issues Letter to Shareholders Correcting False and Misleading Statements in SomaLogic’s Recent Investor Presentation
-
Sustainability Roundtable, Inc Announces 2023 SBER Awards
-
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
-
Madryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company’s Proposed Merger with Standard BioTools
-
Thermo Fisher Scientific Establishes 2030 Renewable Electricity Goal and Solar Power Purchase Agreement with ib vogt
-
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
-
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
-
Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences
-
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
-
Thermo Fisher Scientific Declares Quarterly Dividend
-
Thermo Fisher Scientific Commences Tender Offer for All Outstanding Common Shares and ADSs of Olink
-
Thermo Fisher Scientific Reports Third Quarter 2023 Results
-
Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics
-
ViroCell Expands Business Development Team to Support Next Phase of Growth
-
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 25, 2023
-
Nation’s Top 10 Most Transparent Companies Unveiled in Labrador’s 2023 U.S. Transparency Awards
-
Thermo Fisher Scientific and National Minority Quality Forum Collaborate to Make Clinical Research More Accessible to Historically Underserved Communities
-
Thermo Fisher Scientific to Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 13, 2023
-
Thermo Fisher Scientific to Present at Handelsbanken 3rd Annual Life Science Innovation Day on August 30th, 2023
-
Audax Private Equity Completes Sale of CorEvitas
-
Thermo Fisher Scientific Completes Acquisition of CorEvitas
-
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
-
Thermo Fisher Scientific Reports Second Quarter 2023 Results
-
Thermo Fisher Scientific Declares Quarterly Dividend
-
Thermo Fisher Scientific Elects New Director to Board
-
Audax Private Equity Announces Agreement to Sell CorEvitas to Thermo Fisher Scientific
-
Thermo Fisher Scientific to Acquire CorEvitas
-
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2023
-
Thermo Fisher Scientific Introduces Groundbreaking Mass Spectrometer to Revolutionize Biological Discovery
-
Thermo Fisher Scientific Declares Quarterly Dividend
-
Thermo Fisher Scientific Hosts 2023 Investor Day
-
Thermo Fisher Scientific to Present at Bernstein 39th Annual Strategic Decisions Conference on May 31st, 2023
-
Thermo Fisher Scientific Announces FDA Clearance of Breakthrough Immunoassays to Aid in the Risk Assessment of Preeclampsia
-
Thermo Fisher Scientific Releases 2022 Corporate Social Responsibility Report
-
Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next-Generation Sequencing-Based Testing for Cancer Patients in International Markets
-
Thermo Fisher Scientific to Present at BofA Securities 2023 Healthcare Conference on May 10th, 2023
-
ASLAN Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
ASLAN Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
Thermo Fisher Scientific Reports First Quarter 2023 Results
Back to TMO Stock Lookup